You are here: Industry Insights > NHS

News List

Government choose England top pharmacist to address overprescribing and polypharmacy pharmafile
December 14, 2018
England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS.
NICE reject two treatments for fatal, ultra-rare disease – hATTR pharmafile
December 14, 2018
The NHS’ cost effectiveness body NICE has rejected two treatments for the rare inherited condition, hereditary transthyretin-related amyliodsis (hATTR), over concerns as to whether the drugs showed long term benefits.
Experts call for national lung disease plan pharmatimes
December 13, 2018
A British Thoracic Society (BTS) data review found that the number of A&E attendances in England for lung disease has nearly doubled in the last seven years, and stated that the upcoming
NHS long-term plan focuses on preventive health and genomics pharmaphorum
December 12, 2018
Health and social care secretary Matt Hancock today unveils his long-term NHS plan, which focuses on people taking greater responsibility for their health, and recommends genetic technology as a way to prevent illnesses.
NICE reveals new standards for digital tech pharmaphorum
December 12, 2018
NICE has published new standards setting out the requirements needed to develop digital health technologies for the NHS and speed up uptake of products like healthcare apps and wearable devices.
NHS risks losing revenue without data strategy pharmatimes
December 11, 2018
Think tank Reform has warned that the National Health Service risks losing out on huge potential revenue in the future if it does not put in place a strategy to capitalise on the increasing value of its medical data.
NICE give go-ahead to Gilead's Yescarta for adults with lymphoma pharmafile
December 10, 2018
The NHS cost effectiveness body NICE has approved Gilead’s Yescarta for treatment of come adults with lymphoma.
NICE approves Cimzia but blocks Ilumetri in treatment of psoriasis pharmafile
December 07, 2018
UK drug watchdog NICE has announced two new recommendations relating to medicines for the treatment of psoriasis, approving UCB Pharma’s Cimzia (certolizumab pegol) for use on the NHS...
New cancer drugs taking longer to reach NHS patients pharmatimes
December 06, 2018
A new report by The Institute of Cancer Research (ICR) has found that NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use.
NHS to offer new non-invasive procedure for patients with faulty heart valve pharmatimes
December 06, 2018
An innovative, non-invasive procedure to repair faulty valves in the heart has been approved by the National Institute for Health and Care Excellence for use on the NHS.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page